Genia Long
Impact in
- Family Practice top 10%
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy
- Health Systems, Economic Evaluations, Quality of Life
- Innovation Policy and R&D
- Healthcare Policy and Management
Papers in
-
- Pharmaceutical Economics and Policy 12
- Health Systems, Economic Evaluations, Quality of Life 9
-
- Biosimilars and Bioanalytical Methods 5
- Co-authors
- Henry G. Grabowski (10 shared papers)Richard Mortimer (7 shared papers)Iain Cockburn (1 shared paper)David Cutler (5 shared papers)Joseph A. DiMasi (2 shared papers)Ernst R. Berndt (3 shared papers)Pierre Y. Crémieux (2 shared papers)Andrée-Anne Fournier (2 shared papers)
- Journals
- Journal of Medical Economics (6 papers)Health Affairs (5 papers)PharmacoEconomics (1 paper)Value in Health (1 paper)Nature Reviews Drug Discovery (1 paper)
- Partner nations
- United StatesSingaporeChina
In The Last Decade
Genia Long
19 papers receiving 381 citations
Peers
Comparison fields: 5 of 75
- Family Practice 20
- Economics and Econometrics 251
- Management of Technology and Innovation 51
- Immunology 78
- Pharmacology 27
Countries citing papers authored by Genia Long
This map shows the geographic impact of Genia Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genia Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genia Long more than expected).
Fields of papers citing papers by Genia Long
This network shows the impact of papers produced by Genia Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genia Long. The network helps show where Genia Long may publish in the future.
Co-authors
The 21 scholars most cited alongside Genia Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 90 | |
| 2 | 2006 | 61 | |
| 3 | 2016 | 52 | |
| 4 | 2013 | 49 | |
| 5 | 2015 | 39 | |
| 6 | 2011 | 26 | |
| 7 | Implementation of the biosimilar pathway: economic and policy issues. | 2011 | 16 |
| 8 | 2021 | 15 | |
| 9 | 2010 | 11 | |
| 10 | Insurance switching and mismatch between the costs and benefits of new technologies. | 2017 | 9 |
| 11 | 2024 | 7 | |
| 12 | 2014 | 7 | |
| 13 | 2024 | 5 | |
| 14 | 2013 | 5 | |
| 15 | 2007 | 4 | |
| 16 | 2019 | 3 | |
| 17 | 2021 | 3 | |
| 18 | The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States | 2006 | 2 |
| 19 | 2020 | 1 | |
| 20 | 2025 | 0 |
About Genia Long
Genia Long is a scholar working on Economics and Econometrics, Immunology, Cardiology and Cardiovascular Medicine, General Health Professions and Management of Technology and Innovation, having authored 20 papers that have together received 405 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (12 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Biosimilars and Bioanalytical Methods (5 papers), Global Health Care Issues (3 papers), Blood Pressure and Hypertension Studies (3 papers), Intellectual Property and Patents (2 papers), Chronic Myeloid Leukemia Treatments (1 paper) and Science, Research, and Medicine (1 paper). The work is most often cited by research in Family Practice (20 citations), Economics and Econometrics (251 citations), Management of Technology and Innovation (51 citations), Immunology (78 citations) and Pharmacology (27 citations). Genia Long has collaborated with scholars based in United States, Singapore and China. Frequent co-authors include Henry G. Grabowski, Richard Mortimer, Iain Cockburn, David Cutler, Joseph A. DiMasi, Ernst R. Berndt, Pierre Y. Crémieux, Andrée-Anne Fournier, Alicia Sasser and Noam Y. Kirson. Their work appears in journals such as Journal of Medical Economics, Health Affairs, PharmacoEconomics, Value in Health and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.